Artigos com autorizações de acesso público - Ton N.M. SchumacherSaiba mais
Não disponíveis em nenhum local: 14
Rever
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ...
Nature medicine 25 (6), 920-928, 2019
Autorizações: Dutch Cancer Society
Rever
Cancer neoantigens
TN Schumacher, W Scheper, P Kvistborg
Annual review of immunology 37 (1), 173-200, 2019
Autorizações: European Commission, Dutch Cancer Society
Rever
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
W Scheper, S Kelderman, LF Fanchi, C Linnemann, G Bendle, ...
Nature medicine 25 (1), 89-94, 2019
Autorizações: European Commission, Swiss Cancer League, Dutch Cancer Society
Rever
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
E Strønen, M Toebes, S Kelderman, MM Van Buuren, W Yang, ...
Science 352 (6291), 1337-1341, 2016
Autorizações: US National Institutes of Health, European Commission, Research Council of …
Rever
Adoptive cellular therapy: a race to the finish line
CH June, SR Riddell, TN Schumacher
Science translational medicine 7 (280), 280ps7-280ps7, 2015
Autorizações: US National Institutes of Health
Rever
Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines
S Becattini, D Latorre, F Mele, M Foglierini, C De Gregorio, A Cassotta, ...
Science 347 (6220), 400-406, 2015
Autorizações: Swiss National Science Foundation, European Commission
Rever
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ...
Nature medicine 26 (12), 1839-1844, 2020
Autorizações: Swiss National Science Foundation, Worldwide Cancer Research, UK
Rever
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function
DA Schmid, MB Irving, V Posevitz, M Hebeisen, A Posevitz-Fejfar, ...
The Journal of Immunology 184 (9), 4936-4946, 2010
Autorizações: Swiss National Science Foundation, US National Institutes of Health
Rever
High-throughput identification of antigen-specific TCRs by TCR gene capture
C Linnemann, B Heemskerk, P Kvistborg, RJC Kluin, DA Bolotin, X Chen, ...
Nature medicine 19 (11), 1534-1541, 2013
Autorizações: German Research Foundation, Danish Council for Strategic Research, Dutch …
Rever
Neoantigens encoded in the cancer genome
TN Schumacher, N Hacohen
Current opinion in immunology 41, 98-103, 2016
Autorizações: Dutch Cancer Society
Rever
Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer
GM Bendle, C Linnemann, L Bies, JY Song, TNM Schumacher
The Journal of Immunology 191 (6), 3232-3239, 2013
Autorizações: Dutch Cancer Society
Rever
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection
I Schulte, T Hitziger, S Giugliano, J Timm, H Gold, FM Heinemann, ...
Journal of hepatology 54 (2), 201-208, 2011
Autorizações: German Research Foundation
Rever
Profound immunotherapy response in mismatch repair-deficient breast cancer
M Kok, HM Horlings, P Snaebjornsson, M Chalabi, TN Schumacher, ...
JCO Precision Oncology 1, 1-3, 2017
Autorizações: Dutch Cancer Society
Rever
An atlas of intratumoral T cells
AM van der Leun, TN Schumacher
Science 374 (6574), 1446-1447, 2021
Autorizações: US National Science Foundation
Disponíveis em algum local: 134
Rever
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
nature 500 (7463), 415-421, 2013
Autorizações: US National Institutes of Health, Wellcome Trust
Rever
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
Autorizações: US National Institutes of Health, Cancer Research UK
Rever
Neoantigens in cancer immunotherapy
TN Schumacher, RD Schreiber
Science 348 (6230), 69-74, 2015
Autorizações: US National Institutes of Health, Worldwide Cancer Research, UK, Dutch …
Rever
Mutations associated with acquired resistance to PD-1 blockade in melanoma
JM Zaretsky, A Garcia-Diaz, DS Shin, H Escuin-Ordinas, W Hugo, ...
New England Journal of Medicine 375 (9), 819-829, 2016
Autorizações: US National Institutes of Health
Rever
The human cell atlas
A Regev, SA Teichmann, ES Lander, I Amit, C Benoist, E Birney, ...
elife 6, e27041, 2017
Autorizações: US National Institutes of Health, UK Biotechnology and Biological Sciences …
Rever
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
MM Gubin, X Zhang, H Schuster, E Caron, JP Ward, T Noguchi, Y Ivanova, ...
Nature 515 (7528), 577-581, 2014
Autorizações: US National Institutes of Health, Dutch Cancer Society, Susan G. Komen
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.